Total Hip Arthroplasty: Inflammatory Arthritis

Description

Dr Jonathan Vigdorchik gives his insights as he discusses total hip arthroplasty (THA), primarily focusing on patients with osteoarthritis and other types of arthritis who are often treated with biologic medications. He highlights the importance of understanding the dosing intervals of these medications, including methotrexate and others, before and after surgery to minimize the risk of infection. Key points include needing to pause certain medications around the time of surgery based on their half-lives, and guidelines provided by organizations like the American College of Rheumatology to aid in managing these drugs. Postoperative care is also covered, emphasizing that medications can generally be resumed three to four weeks after surgery when the wound has healed. Overall, the audio serves as a guide for healthcare professionals in managing the medication regimens of patients undergoing hip replacement surgery.

DOI: 10.1302/3114-251147

Specialties